Sartorius Stedim Biotech(GB:0RG8)
€226.80+3.60 (+1.61%)
GB:0RG8
Sartorius Stedim Biotech financials statements
€226.80
At close:+3.60 (+1.61%)
Sartorius Stedim Biotech (0RG8) Financial Statements
2 Followers
Sartorius Stedim Biotech Financial Overview
Sartorius Stedim Biotech's market cap is currently €21.82B. The company's EPS TTM is €3.34; its P/E ratio is 67.90; and it has a dividend yield of 0.31%. Sartorius Stedim Biotech is estimated to report earnings on February 23, 2027, and the estimated EPS forecast is €1.47. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | € 2.97B | € 2.78B | € 2.78B | € 3.49B | € 2.89B |
| Gross Profit | € 1.35B | € 1.21B | € 1.23B | € 1.82B | € 1.55B |
| Operating Income | € 549.00M | € 370.60M | € 484.50M | € 1.10B | € 912.67M |
| EBITDA | € 867.10M | € 670.50M | € 755.70M | € 1.33B | € 811.96M |
| Net Income | € 265.60M | € 175.10M | € 309.70M | € 876.10M | € 414.40M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | € 434.20M | € 688.80M | € 126.10M | € 133.00M | € 237.35M |
| Total Assets | € 8.02B | € 8.26B | € 7.74B | € 5.07B | € 3.95B |
| Total Debt | € 2.60B | € 2.87B | € 3.68B | € 1.14B | € 625.52M |
| Net Debt | € 2.17B | € 2.19B | € 3.57B | € 1.03B | € 401.89M |
| Total Liabilities | € 3.89B | € 4.23B | € 5.07B | € 2.55B | € 2.22B |
| Stockholders' Equity | € 4.09B | € 3.99B | € 2.64B | € 2.45B | € 1.66B |
| Cash Flow | |||||
| Free Cash Flow | € 145.40M | € 475.30M | € 156.10M | € 181.70M | € 371.98M |
| Operating Cash Flow | € 538.60M | € 815.10M | € 746.40M | € 612.30M | € 695.97M |
| Investing Cash Flow | € -397.70M | € -340.00M | € -2.72B | € -957.50M | € -465.23M |
| Financing Cash Flow | € -389.20M | € 84.90M | € 1.99B | € 220.70M | € -69.27M |
Currency in EUR

